Ticlopidine Pretreatment Before Coronary Stenting Is associated With Sustsained Decrease of Adverse Cardiac Events: Data From the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (Epistent Trial) - EPISTENT Trial Ticlopidine Pre-treatment Substudy

Description:

Ticlopidine Pretreatment Before Coronary Stenting Is associated With Sustsained Decrease of Adverse Cardiac Events: Data From the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (Epistent Trial).